This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Cost-effectiveness Analysis

Marc D. Silverstein, MD; Albert G. Mulley, MD, MPP; Jules L. Dienstag, MD

JAMA. 1984;252(20):2839-2845.

Abstract
We examined the cost-effectiveness of alanine aminotransferase (ALT) screening of donor blood to prevent non-A, non-B posttransfusion hepatitis. Based on estimated costs of ALT screening, blood replacement, and medical evaluation of donors with high ALT levels, we concluded that screening at an ALT level of 45 IU would cost $3.82 per unit. In a population requiring an average of 3.7 units per transfusion, one case of hepatitis would be prevented for every 115 units screened, resulting in a cost of $439 per case prevented. With an estimated direct medical cost of $1,181 per case of non-A, non-B hepatitis, expected net savings for each case prevented would be $742. Screening at other ALT thresholds would be less cost-saving. Sensitivity analyses indicate that screening would be cost-saving for a wide range of cost estimates and number of units per transfusion. Alanine aminotransferase screening is warranted until more sensitive and specific screening tests for transmissibility of non-A, non-B hepatitis become available.

(JAMA 1984;252:2839-2845)

Author Affiliations
From the General Internal Medicine and Medical Practices Evaluation Units (Dr Mulley) and the Gastrointestinal Unit (Dr Dienstag), Massachusetts General Hospital, the Department of Medicine, Harvard Medical School (Drs Mulley and Dienstag), Boston; and the Section of General Internal Medicine, Department of Medicine, University of Chicago (Dr Silverstein).

Footnotes
Reprint requests to the Department of Medicine, University of Chicago, 5841 S Maryland Ave, Box 72, Chicago, IL 60637 (Dr Silverstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Blood Donors with Elevated Serum Alanine Aminotransferase Levels
FRIEDMAN et al.
ANN INTERN MED 1987;107:137-144.
ABSTRACT  

Screening of Donor Blood for Alanine Aminotransferase
Fiedler
JAMA 1985;254:3422-3422.
ABSTRACT  

Screening for HTLV-III Antibodies: The Relation Between Prevalence and Positive Predictive Value and Its Social Consequences
Barry et al.
JAMA 1985;253:3395-3396.
ABSTRACT